48 episodes

Nature Biotechnology's First Rounders podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.

First Rounders Nature Biotechnology

    • Natural Sciences
    • 4.6, 45 Ratings

Nature Biotechnology's First Rounders podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.

    Katrine Bosley

    Katrine Bosley

    Katrine Bosley is former CEO of Editas Medicines and Avila Therapeutics. She discusses growing up in Ohio, her first job in biotech (as an administrative assistant) and why her five years at CRISPR company Editas felt more like 1,000. This episode is part of Nature Biotechnology's focus issue on translating the CRISPR technology.
     
    See acast.com/privacy for privacy and opt-out information.

    • 1 hr 8 min
    Ted Love

    Ted Love

    Ted Love is the president and CEO of Global Blood Therapeutics. In his conversation with Nature Biotechnology, he discusses why his time at Haverford College was transformative, why he views Global Blood Therapeutics as a social justice company, and what might be gained from the “racial catharsis” happening in America after the police killing of George Floyd.
     
    See acast.com/privacy for privacy and opt-out information.

    • 1 hr 22 min
    Alexis Borisy

    Alexis Borisy

    Alexis Borisy is CEO and Chairman of EQRx, and a long-time biotech builder with Third Rock Ventures. His conversation with Nature Biotechnology covers growing up as a “faculty brat” in Wisconsin, dropping out of his PhD program at Harvard and why, even as an investor, biotech cannot be all about the money. 
     
    See acast.com/privacy for privacy and opt-out information.

    • 1 hr 5 min
    Bonus: Jeremy Levin

    Bonus: Jeremy Levin

    A conversation with Jeremy Levin, chairman of the Biotechnology Innovation Organization and CEO of Ovid Therapeutics, about industry versus government responses to covid19, the split within biotech on how to address charges of high prices, and why the biopharma industry is so disliked. 
     
    See acast.com/privacy for privacy and opt-out information.

    • 46 min
    Bassil Dahiyat

    Bassil Dahiyat

    Bassil Dahiyat is co-founder, president and CEO of Xencor. His conversation with Nature Biotechnology covers his parents emigrating from Jordan, how Xencor has survived (and changed) over the past 22 years, and when it’s necessary for a CEO to speak out.
     
    See acast.com/privacy for privacy and opt-out information.

    • 1 hr 3 min
    Forum: Schneeberger on Clavien

    Forum: Schneeberger on Clavien

    Senior Editor Irene Jarchum talks to Stefan Schneeberger about the significance of a recent Nature Biotechnology paper describing a sophisticated perfusion machine to keep human livers alive for a week. The work was carried out by Pierre-Alain Clavien and colleagues from ETH Zurich. Read the paper here.
     
    See acast.com/privacy for privacy and opt-out information.

    • 22 min

Customer Reviews

4.6 out of 5
45 Ratings

45 Ratings

Evillllldr ,

Great interview style

I’m an active biomedical researcher. I love how the interviewer ask common sense questions and also stick with the science/inspirations. Doing great, keep it going!

KevinZumwalt ,

Inspirational

I started listening to this podcast just a couple days ago, and I’m hooked. I love the personal anecdotes and insight, and stick around for the ideas and inspiration. As someone interested in bio technology and its future, this is the Podcast for us

renob5551212 ,

Unfocused, poor interview style

Way too much time spent on things that are, frankly, uninteresting. The easiest solution to this issue is cut the duration in half.

Top Podcasts In Natural Sciences

Listeners Also Subscribed To